युनायटेड केअर हॉस्पिटल, एन-३ सिडको · +91 76889 29292 Englishमराठीहिंदी
श्री वी केअर क्लिनिकरक्तविकार व कर्करोग उपचार केंद्र अपॉइंटमेंट घ्या
मुख्यपृष्ठ › डॉक्टर › डॉ. अनुप तोष्णीवाल
Dr. Anup Toshniwal
कर्करोग तज्ज्ञ (मेडिकल ऑन्कॉलॉजिस्ट)

डॉ. अनुप तोष्णीवाल

MBBS, MD (Medicine), DM (Medical Oncology – Tata Memorial Hospital, Mumbai)

डॉ. अनुप तोष्णीवाल हे टाटा मेमोरियल हॉस्पिटल, मुंबई येथे प्रशिक्षित कर्करोग तज्ज्ञ आहेत. ते सर्व प्रकारच्या कर्करोगांवर व रक्ताच्या कर्करोगावर केमोथेरपी, टार्गेटेड थेरपी व इम्युनोथेरपीद्वारे उपचार करतात.

तज्ज्ञता

  • Chemotherapy, targeted therapy and immunotherapy for all solid cancers
  • Breast, lung, gastrointestinal, gall bladder, head & neck, gynaecological and urological cancers
  • Lymphoma, leukaemia and myeloma (hemato-oncology)
  • Bone marrow aspiration & biopsy, lumbar puncture, intrathecal chemotherapy
  • Second opinions and tumour board review

शिक्षण

  • MBBS – Government Medical College, Chhatrapati Sambhajinagar
  • MD (General Medicine) – Kasturba Medical College, Mangalore
  • DM (Medical Oncology) – Tata Memorial Hospital, Mumbai
  • ESMO certification – European Society for Medical Oncology
  • ACORD Fellow – Clinical Oncology Research Development workshop, Australia

पदे व अनुभव

  • Senior Consultant Medical Oncologist – Medicover Hospital, Chhatrapati Sambhajinagar
  • Associate Professor – Government Cancer Hospital, Chhatrapati Sambhajinagar
  • Former Assistant Professor – Tata Memorial Hospital, Mumbai
  • Teaching faculty for DM (Medical Oncology) and MD (Medicine) courses
  • Director – Shree We Care Clinic

प्रकाशित संशोधन

  • Downstaging with neoadjuvant chemotherapy in locally advanced gall bladder cancer improves outcomes – Annals of Oncology
  • Toxicity and early outcomes of regorafenib in multiply pre-treated metastatic colorectal adenocarcinoma – experience from a tertiary cancer centre in India
  • Modified 5-FU / leucovorin / irinotecan as a feasible and efficacious second-line regimen in advanced gastric cancer
  • Quality-of-life (Q-TWiST) analysis of a randomised trial comparing cabazitaxel versus docetaxel in recurrent head and neck cancer
  • Efficacy of artesunate for cytomegalovirus reactivation in allogeneic stem cell transplant recipients
  • Use of leflunomide for cytomegalovirus infection in allogeneic stem cell transplant recipients
  • NUT midline carcinoma (case report)
  • Bleomycin-induced skin rash (case report)